American biopharmaceutical company with its headquarters and main research campus on North Waukegan Road at North Chicago in Illinois, spun out of Abbott Laboratories in 2013 and listed in New York. Researches, develops, makes and sells medicines in immunology with adalimumab, risankizumab and upadacitinib, in oncology with ibrutinib and venetoclax, in neuroscience and eye care, and it owns the Allergan aesthetics business including Botox, running its own discovery research, clinical development and manufacturing worldwide.
Aucun commentaire disponible.
Laissez votre note & commentaire